Lincoln Pharmaceuticals Limited Financial Ratios
LINCOLN · Healthcare · Current price ₹557.95
P/E ratio
11.4x
P/B ratio
1.7x
ROE
0.0%
ROCE
15.3%
Debt / Equity
0.01
Dividend yield
0.3%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 11.4x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 1.7x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 0.0% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 15.3% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.01 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Lincoln Pharmaceuticals Limited's latest numbers.
Lincoln Pharmaceuticals Limited profitability
Lincoln Pharmaceuticals Limited generates a return on equity of 0.0% and a return on capital employed of 15.3%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.01 and a P/E of 11.4x, Lincoln Pharmaceuticals Limited is conservatively financed. Our overall business-quality score for the company is 4.7 / 10.
Understand the ratios
More on Lincoln Pharmaceuticals Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.